SYNPO2 and kidney neoplasm: In a cohort study involving 88 kidney tumor samples, 50 cases (56.8%) revealed an association between the methylation status of the SYNPO2 and the Memorial Sloan-Kettering Cancer Center (MSKCC) risk score and distant metastasis [14].